blood clots semaglutide and Thinners: Safety and Interactions Dear Doctor: Is there evidence

A: For pleasure

Saxenda, also an incretin mimetic, was approved for obesity with the active ingredient liraglutide (and previously approved for type 2 diabetes under the name Victoza) as a daily injection

These can include: Digestive issues that could lead to dehydration and cause kidney damage Gastrointestinal issues like pancreatitis or gallbladder disease Low blood pressure Low blood sugar levels There is also a black box warning, the most serious kind from the FDA, on both medications for the risk of a certain rare type of thyroid cancer

These treatments significantly increase the likelihood of successfully quitting compared to willpower alone, and they are available through NHS Stop Smoking Services, GP surgeries, and community pharmacies across the UK